chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Extreme fatigue, all over joint pain, severe headache and fever to 101.6 F starting a day after vaccination . The next morning, still achy and fatigued but temp normal.  Fatigue and headache lasted 3-4 days. sore arm with lump for a week.  After the first dose, which was done on  12/20/2020, I had achiness the next day and mild headache but no fever as far as I know.
COVID 19 Treatment; COVID 19 Treatment; vaccine brand other=Moderna on 02Dec2021/vaccine brand other=Moderna on 15Apr2022; This is a spontaneous report received from a contactable consumer. The reporter is the patient. A 57-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 26Oct2022 at 12:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 57 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 04Feb2021 at 10:30 as dose 1, single (Lot number: EL9269), in left arm and on 25Feb2021 as dose 2, single (Lot number: En6198), in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 02Dec2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 15Apr2022 at 16:30 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Erythromycin, reaction(s): "known allergies: Erythromycin". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 02Dec2021 at 12:00, outcome "unknown", described as "vaccine brand other=Moderna on 02Dec2021/vaccine brand other=Moderna on 15Apr2022"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Apr2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Apr2023) Positive, notes: Positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Respiratory distress with stridor 2 Rasmic Epi Nebulizer Epi SQ. The follow up states, "diagnosed with allergy to DTaP."  Nurse follow up on 06/18/04 states: "ADD: Stridor, ADD: subglottic edema."
See attached progress note. 1pm on 5-5-11 dizzy, weak progressed throughout afternoon to foot & leg pain. She also developed a headache & arm pain.
Information has been received from a physician concerning a 12 year old 25 kg patient who was vaccinated on an unspecified date with a dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccination included a dose of Menactra. Subsequently, the patient developed an unspecified allergic reaction. The patient was treated with a one time dose of Orapred 45 mg. No further information was provided. There was no product quality complaint involved. Follow up information has been received from another health care professional concerning this 12 year old male with cellulitis and a latex allergy who was vaccinated SC in the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (lot # 658018/1007U) on 28-AUG-2007. Fifteen minutes after vaccination the patient had facial swelling and throat irritation. Unspecified medical attention was sought. On an unspecified date the patient recovered. There were no adverse events following prior vaccination. Additional information is not expected.
Patient had a fever, aches, pain, tiredness, sore arm lasting 3 days
FLUMIST vaccine given 10-30-14. No symptoms from vaccine and no treatment needed.
Red hot sore arm, severe combined with radiating pain in arm then to joints - systemic.  Developed aphthous ulcers oral and genital with fever.  Elevated temp and aches 5 days later.  Has had vaccines in the past with no known reactions.  Saw MD - no cellulitis dx.
Rash on abdomen, back and underarm; Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site; Strong pain on the injection site; Redness at the injection site; Swelling at the injection site; Low fever; Chills; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site) and VACCINATION SITE SWELLING (Swelling at the injection site) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Low fever) and CHILLS (Chills). At the time of the report, RASH (Rash on abdomen, back and underarm), VACCINATION SITE URTICARIA (Redness at the injection site "like a ring" or like "mosquito bite", swollen up from the injection site), VACCINATION SITE PAIN (Strong pain on the injection site), VACCINATION SITE ERYTHEMA (Redness at the injection site), VACCINATION SITE SWELLING (Swelling at the injection site), PYREXIA (Low fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  Treatment information was not provided.
Moderna COVID-19 Vaccine EUA,   Adverse effect: Soreness at injection site on next day after injection.  Soreness went away in 1 day.   Then Dollar size raised hive at injection site, itchy, reddened- 1 week and 1/2 after injection administered.
constantly thirsty; soreness inside the mouth; fever; body chills; vomiting (puking); body ache; diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), THIRST (constantly thirsty), ORAL PAIN (soreness inside the mouth), PYREXIA (fever) and CHILLS (body chills) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced DIARRHOEA (diarrhea), PYREXIA (fever), CHILLS (body chills), VOMITING (vomiting (puking)) and MYALGIA (body ache). On 16-Mar-2021, the patient experienced THIRST (constantly thirsty) and ORAL PAIN (soreness inside the mouth). At the time of the report, DIARRHOEA (diarrhea), PYREXIA (fever), CHILLS (body chills), VOMITING (vomiting (puking)) and MYALGIA (body ache) had resolved and THIRST (constantly thirsty) and ORAL PAIN (soreness inside the mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included high blood pressure medication (unspecified).  No treatment information was provided.
At three weeks of age, pt became extremely irritable, did not want to eat, did not sleep or rest easily, and spit up. He never was content. Numerous trips to pediatrician, GI consult, GI testing (upper GI series, ultrasound, ph probe) done. Nothing significant showed on tests. Shows lack of responsiveness, little bonding, speech and language delays. Screened for early intervention and evaluated for speech and language (7 months behind). At 14 months 3/02, pt was diagnosed with mercury poisoning.
Pt received COVID vaccine in February/March and was found to be COVID-19 positive on 6/10/21. Pt was asymptomatic.
I woke up with a runny nose and a light cough. It was so mild I didn't think I was sick. Other people in my family were sick and suggested we take a COVID-19 test. The result was positive. I sneezed a few times. I didn't have a fever. I contacted my doctor. They prescribed Paxlovid. I felt normal except for mild symptoms, but I had tightness in my chest when walking up steps or walking to the end of the block. I had to sit down for a minute or two when I got to the top step. It?s very brief, but I rest when I feel it and it goes away. I usually walk 4 miles a day or work out for an hour at the gym, and I?ve never felt that kind of tightness in my chest. Currently, I seem to be doing fine.
Patient admitted as inpatient on 9/6 due to acute respiratory failure with hypoxia 2/2 COVID pneumonia. Patient was tested for COVID-19 and was positive on 8/29.
bubble blister appeared at injection site, not hot to touch, no rash (just blister) , patient did not report history of latex allergy at time of vaccine (nitrile gloves used, and bandaids were used - box states not made with natural latex)
Just pain in the arm (muscle soreness); Just pain in the arm (muscle soreness); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Just pain in the arm (muscle soreness)) and MYALGIA (Just pain in the arm (muscle soreness)) in a 31-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (Just pain in the arm (muscle soreness)) and MYALGIA (Just pain in the arm (muscle soreness)). On 21-Feb-2021, PAIN IN EXTREMITY (Just pain in the arm (muscle soreness)) and MYALGIA (Just pain in the arm (muscle soreness)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.  Treatment information was not provided.   Reporter did not allow further contact
Headache, Myalgia, fatigue Narrative:  headache, myalgia, fatigue next day after injection
expired dose of Engerix-B given; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 15-year-old male patient who received HBV (Engerix B) (batch number YL2L3, expiry date 14th October 2021) for prophylaxis.   On 28th October 2021, the patient received Engerix B. On 28th October 2021, unknown after receiving Engerix B, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The pharmacist reported that patient was administered Engerix B which was expired on 14th October 2021, which led to expired vaccine used. The reporter consented to follow up.
tingling in right leg; pain in right leg; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in right leg) and PAIN IN EXTREMITY (pain in right leg) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced PARAESTHESIA (tingling in right leg) and PAIN IN EXTREMITY (pain in right leg). At the time of the report, PARAESTHESIA (tingling in right leg) and PAIN IN EXTREMITY (pain in right leg) outcome was unknown.            Concomitant medication of the patient was not reported.  On 30-Sep-2021, the patient woke up and started driving her son to school. She started having tingling and pain in her right leg. It hurt and tingles even when she was sitting still.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-338511 (Patient Link).
Patient received second Moderna vaccine at age 17, Moderna is approved for ages 18 and up.
was very itchy; her hand started tingling; I broke out with the rash; it got worse; I broke out with the rash; it got worse; I can't sleep; It's driving patient crazy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202101352055 (PFIZER).  A 75 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Oct2021 (Lot number: EW0196) at the age of 75 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose:1), administration date: 2021, when the patient was 75 years old, for COVID-19 immunization; Bnt162b2 (Dose:2), administration date: 2021, when the patient was 75 years old, for COVID-19 immunization. The following information was reported: RASH (non-serious), CONDITION AGGRAVATED (non-serious) all with onset 04Oct2021, outcome "not recovered" and all described as "I broke out with the rash; it got worse"; SLEEP DISORDER (non-serious) with onset Oct2021, outcome "unknown", described as "I can't sleep"; FEELING ABNORMAL (non-serious) with onset Oct2021, outcome "unknown", described as "It's driving patient crazy"; PRURITUS (non-serious), outcome "unknown", described as "was very itchy"; PARAESTHESIA (non-serious) with onset 04Oct2021, outcome "unknown", described as "her hand started tingling". The event "i broke out with the rash; it got worse" and "i broke out with the rash; it got worse" was evaluated at the physician office visit. Therapeutic measures were taken as a result of rash, condition aggravated, pruritus.  Additional Information: she took the booster shot last Monday 04Oct2021, she rested for a couple of minutes after receiving the shot and when she's leaving the parking lot, her hand started tingling, her hands got really itchy, and after couple of minutes it started breaking out to different parts of her body. She also added that she's been to her doctor already couple of times and gave her Prednisone, Benadryl and some Claritin but it's not working. Per caller, she had no problem or side effects to the 1st 2 doses of Pfizer BioNTech Covid19 Vaccine that she received and she's calling asking what to do with this terrible very itchy rash. Patient taking other unspecified concomitant medications . Patient had no any lab work after the shot. Patient had not prior vaccinations within 4 weeks.  No follow-up attempts are possible. No further information is expected.
Case number PHHY2012US051655 is an initial literature report received on 12 Jun 2012. Authors searched VAERS for reports of adverse events (AEs) in pregnant women who received influenza vaccine from 01 Jul 1999 through 30 Jun 2009. This case refers to a baby born (sex not specified) to mother (age not specified). The mother was vaccinated with influenza vaccine (manufacturer and batch number: unknown) at an unknown gestational age, on an unspecified date between 01 Jul 1999 through 30 Jun 2009 (see linked mother file: PHHY2012US051651). The fetus was exposed to this vaccine via transplacental route. On an unknown date at an unspecified gestational period, the baby was born. On an unspecified date, the baby developed meningitis. The causality was not reported. Authors stated that the VAERS system does not allow for active follow-up of adverse events among pregnant women; thus, pregnancy outcome data are not available for women who had an adverse pregnancy event. Authors concluded that no unusual patterns of pregnancy complications or fetal outcomes were observed in the VAERS reports of pregnant women after the administration of influenza vaccine.
Pt. reported a metallic taste in his mouth about 5-10 min. after receiving his 2nd dose of HBV on 1/28/2005.  Also reported feeling "blah" for 3 or 4 days after receiving vaccine.  Pt. has a history of asthma; did not report any exacerbation of asthmatic symptoms after receiving vaccine; neither did he report any hives or pruritis.  Symptoms resolved without medication or medical intervention.
Rigors, chills, fatigue, myalgia, headache, low grade fever, diarrhea, anorexia
Initial information has been received from a physician concerning a 56 year old female who on 09-JUN-2008 was vaccinated with a dose of ZOSTAVAX vaccine (Oka/Merck) (lot number not provided). Concomitant therapy included ALLEGRA, LIPITOR, CELEBREX, aspirin, WELLBUTRIN, DIFLUCAN, and PROTONIX. On 10-JUN-2008 the patient developed redness, swelling, tenderness and warmth. It was unspecified where on the body patient had this . No further information was provided. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Generalized aches and pains with headache, anorexia, chills (temperature not taken); and redness at injection site covering more than 1/2 the upper arm that was firm and tender. I slept 15 hours a day for three days.
Immediately upon administration of covid19 vaccination, patient became flushed (face and arms), dizzy and nauseous.  Patient also reported vision changes (seeing spots)  Flushing resolved in about 5 minutes and nausea/dizziness in about 10-15 minutes while patient was monitored by pharmacy staff.  Patient reported heavy breathing at this time believed due to anxiety but was continued to be monitored by staff.  After about 20 minutes patient was able to stand briefly and moved to another chair to relax and to continue monitoring.  At this time most symptoms had resolved but patient still reported feeling uneasy and a little disoriented.  Water was provided and pharmacy staff continued to sit with patient until patient felt that she had calmed down and reported no further adverse conditions.  After sitting for another 10 minutes patient stood on her own, was stable and felt comfortable returning to work.
24 hours after vaccination felt instant  dizziness and nausea and fell against the wall. Crawled to the bed and collapsed. Stayed in bed with head flat for 2 days. Had to be helped to the bathroom. No walking capabilities. Gradually started coming out of it on the third day, still not able to have head up while trying to eat and drink. 4th day better in the morning with head up and walking. Seemingly gone by evening. Horrible episode.
Vertigo (BPPV), pressure on neck (felt like congestion along along neck leading to ear), vestibular hypofunction leading to nausea, erratic and high blood pressure, elevated thyroid.   All symptoms continue. Seeing primary care physician and physical therapist. Now on losartan 100 mg which is not helping. Blood pressure still high and erratic. Pressure in ears, head aches.
PT recd 2 doses of Engerix-B (1 vial/IM 8APR91 & 14MAY91); devd scapular & chest pain & exertional dyspnea which lasted for 48 hrs; reporting pharmacist indicated that events were life-threatening; PT reported to have recovered;
Five siblings came in to get COVID-19 vaccinations (or boosters) and their mother was handing the paperwork to the pharmacist one by one to correspond with the correct patient. Paperwork handed to RPH, was actually the form for the 11 yo sibling and other siblinling, the peds dose was given instead of the adult dose. Mother was notified immediately when mistake was caught. This was supposed to be her booster dose.
10 days after, I woke in the am with severe vertigo. Have had every day since then and it lessens as the day goes on. About a week after started, I got significant tints for about 15 and it gradually lessened. That has happened a few more times since then and there is a constant mild tinitis.
Starting on the 3rd day, started getting electrical buzzes in my vision when looking left to right and then it traveled to arms and wrists. Called neurologist and she insisted that I go to the ER and then my body started going in convulsions but I wasn't having seizures. I was fully aware of my body jerking for over 5-6 hours. I had asked to be secured but the ER staff didn't help me. It took me a few weeks to recover but mostly from the convulsions and causing me whiplash. Had an MRA to clear for possible blood clot.
5/13/10 Doctor gave VARIVAX, MMR #1, Hep A#1. Mother called 5/25/10 stating patient had a rash all over her body. Red raised spots. Experiencing itching with no other signs or symptoms. Patient's cousin has same shot, chickenpox on same day and had same rash that started 5/24/10.
Chief Complaint  92y/o male here for increased SOA, lethargy and fever today.  Dx with pneumonia X2 days ago, placed on ABTs.  Pt hypoxic, mid-80s upon EMS arrival, febrile, with productive cough History of Present Illness  92yo man with h/o parkinsons with dysphagia, HTN, paroxysmal afib, prior CVA and SAH thus not on chronic anticoagulation, presenting from a nursing home with 2-3 days of cough and fatigue.  Reportedly at his baseline, and he denies fevers, chills, nausea, or pain.  Cannot tell me why he is in the ED.  He was vaccinated for COVID earlier this year in the Spring it is believed, and he is today COVID-19 positive.  Does not know his meds, but started on Augmentin 2 days
Developed burning pain on the left posterior side of her chest going down front the chest four days after ZOSTAVAX. Rash began about 7 days after ZOSTAVAX. Treated with valacyclovir 1 g TID x 7 days and hydrocodone/APAP 5/325.
Arm is sore; Arm, neck and head is stiff; Can't sleep well; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is sore), MUSCULOSKELETAL STIFFNESS (Arm, neck and head is stiff) and SLEEP DISORDER (Can't sleep well) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm is sore), MUSCULOSKELETAL STIFFNESS (Arm, neck and head is stiff) and SLEEP DISORDER (Can't sleep well). At the time of the report, PAIN IN EXTREMITY (Arm is sore), MUSCULOSKELETAL STIFFNESS (Arm, neck and head is stiff) and SLEEP DISORDER (Can't sleep well) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Updated events outcome to recovered, Denied for further Follow up
BLOTCHY AREA TO CHEST, PERIORAL REDNESS WITH DRY SKIN. PERIORBITAL DRYNESS.  Narrative:
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 11-NOV-2010, the patient was vaccinated with improperly stored VARIVAX dose 2 (dose unknown), from lot # 666851/0280Z with expiry date of 12-FEB-2012.  No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.